HNF1A-AS1 promotes oral squamous cell carcinoma progression via regulating miR-138/CDK6 pathway

被引:0
|
作者
Mei, Bingxin [1 ]
Zeng, Zhimei [1 ]
Xia, Qinmin [1 ]
Liu, Ming [1 ]
Lei, Li [1 ]
机构
[1] Gannan Med Univ, Dept Stomatol, Affiliated Hosp 1, 128 Jinling Rd, Ganzhou 341000, Jiangxi, Peoples R China
关键词
HNF1A-AS1; miR-138; CDK6; Progression; OSCC; UP-REGULATION; RESISTANCE;
D O I
10.1007/s10266-025-01057-w
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The action and the latent mechanism of HNF1A-AS1 in oral squamous cell carcinoma (OSCC) development were probed. Levels of HNF1A-AS1, microRNA-138 (miR-138) and Cyclin-dependent kinase 6 (CDK6) were examined. In vitro assays were conducted using SCC-4 and SCC15 cells derived from a human SCC of the tongue of a 55-year-old male. In vivo assay was performed by establishing OSCC mouse models. An elevated HNF1A-AS1 was detected in OSCC, and down-expressed HNF1A-AS1 inhibited migration and invasion, and promoted apoptosis in OSCC cells in vitro. HNF1A-AS1 targeted miR-138 to positively regulate the expression of CDK6, a target of miR-138. Knockdown of miR-138 attenuated the action of HNF1A-AS1 silencing on OSCC cell malignant phenotypes. Besides that, overexpression of CDK6 weakened miR-138-mediated anti-cancer functions. Moreover, HNF1A-AS1 knockdown restrained OSCC growth in nude mice. HNF1A-AS1 promoted OSCC tumorigenesis via miR-138/CDK6 pathway, indicating the potential molecular contribution of HNF1A-AS1 on OSCC pathogenesis.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] In situ measurement of miR-138 expression in oral squamous cell carcinoma tissue supports the role of this microRNA as a tumor suppressor
    Zeng, Dequan
    Xu, Hao
    Ji, Ning
    Li, Jing
    Zhou, Min
    Dan, Hongxia
    Zhou, Yu
    Zeng, Xin
    Jiang, Lu
    Chen, Qianming
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2019, 48 (10) : 911 - 918
  • [32] CircRNA circ_POLA2 Promotes Cervical Squamous Cell Carcinoma Progression via Regulating miR-326/GNB1
    Cao, Yuan
    Li, Juan
    Jia, Yanyan
    Zhang, Ruitao
    Shi, Huirong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma
    Li, Ling
    Lu, Shun
    Liang, Xinhua
    Cao, Bangrong
    Wang, Shaoxin
    Jiang, Jian
    Luo, Huaichao
    He, Shuya
    Lang, Jinyi
    Zhu, Guiquan
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 14 : 101 - 113
  • [34] LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
    Ma, Jing
    Qi, Guanbin
    Li, Lei
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2020, 25 (01)
  • [35] LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
    Jing Ma
    Guanbin Qi
    Lei Li
    Cellular & Molecular Biology Letters, 2020, 25
  • [36] LncRNA LUADT1 Promotes Oral Squamous Cell Carcinoma Cell Proliferation by Regulating miR-34a/GAS1 Axis
    Gao, Lirong
    Wang, Siming
    Meng, Junru
    Sun, Yugang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3401 - 3407
  • [37] Circular RNA ERBIN Promotes Proliferation of Hepatocellular Carcinoma via the miR-1263/CDK6 Axis
    Yang, Shikun
    Yu, Fei
    Ji, Yang
    Shen, Yanjun
    Lu, Hao
    Gao, Yuan
    Zhang, Feng
    Wang, Xuehao
    Zhang, Chuanyong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer
    Zhang, Guoyu
    An, Xiaokang
    Zhao, Huiya
    Zhang, Qingyong
    Zhao, Hui
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 594 - 599
  • [39] AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-13/Akt-Cyclin D1/CDK6 Pathway
    Gao, Yanjun
    Li, Yingge
    Liu, Zheming
    Dong, Yi
    Yang, Siqi
    Wu, Bin
    Xiao, Mengxia
    Chen, Chen
    Wen, Yingmei
    Chen, Lei
    Jiang, Haijuan
    Yao, Yi
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 2021 - 2036
  • [40] Stromal expression of AEBP1 promotes progression of oral squamous cell carcinoma
    Sekiguchi, Shohei
    Okazaki, Fumika
    Yorozu, Akira
    Yamamoto, Eiichiro
    Niinuma, Takeshi
    Takasawa, Akira
    Hatanaka, Yui
    Kitajima, Hiroshi
    Kai, Masahiro
    Osanai, Makoto
    Hirohashi, Yoshihiko
    Torigoe, Toshihiko
    Kojima, Takashi
    Takano, Kenichi
    Miyazaki, Akihiro
    Suzuki, Hiromu
    CANCER SCIENCE, 2024, 115 : 1426 - 1426